Identification of Bakuchiol as Potent Bacterial Neuraminidase Inhibitor from Psoralea corylifolia
Bakuchiol was identified as a potent inhibitor of bacterial neuraminidase with an IC50 of 4.67 μM, outperforming quercetin.
Phase III
Infectious Disease / Antibacterial
Status
Active
Signal Score
8.4
Signal assessment
Signal strength
high
Confidence level
high
Why it matters
The identification of bakuchiol as a potent bacterial neuraminidase inhibitor presents a significant opportunity for the development of novel anti-infective agents. This discovery could disrupt the current antibacterial landscape and necessitates further investigation into its clinical potential and competitive positioning.
Recommended action
Humanexa recommends Investigate.
Analysis
Monitor further preclinical and clinical studies on bakuchiol and its derivatives, as well as competitive responses from established antibacterial developers.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.